Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2024-03-28 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
关于回购股份事项前十大股东和前十大无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the shareholding details of the top ten shareholders and top ten unrestricted shareholders prior to a share repurchase plan. It includes specific shareholding numbers and percentages as of a certain date. The document references a board meeting approving a share repurchase plan and discloses shareholder information as required by regulatory rules. There is no financial statement, earnings data, or management discussion. The content focuses on shareholding changes related to a share repurchase. This fits the category of Transaction in Own Shares (POS), which covers company announcements about buying back or selling its own shares.
2024-03-28 Chinese
第二届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the company's second board of directors. It details the meeting date, attendance, the approval of a share repurchase plan, and the authorization given to management to execute the plan. There are no financial statements or detailed financial performance data included. The document is primarily about board decisions and authorizations related to share repurchase. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short (1080 characters), and it is not a report or a publication announcement but a meeting resolution announcement. Therefore, the correct classification is MANG with high confidence.
2024-03-27 Chinese
关于回购公司股份方案的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement from Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. regarding a share repurchase plan. It includes specifics about the repurchase price range, total funds to be used, number of shares to be repurchased, purpose of the repurchase (for employee stock ownership or equity incentive plans), implementation period, risk warnings, management analysis on the impact of the repurchase, and authorizations for management to execute the plan. The document is not a financial report or earnings release but a formal announcement about the company's plan to buy back its own shares. This fits the definition of a Transaction in Own Shares (POS) filing, which covers share repurchase announcements and plans. The document length is over 6,000 characters and contains substantive details about the repurchase plan, not just a brief notice or a report publication announcement. Therefore, the correct classification is POS with high confidence.
2024-03-27 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions passed at the 2024 first extraordinary general meeting of shareholders of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It details the meeting date, attendance, voting results on various proposals including amendments to the company charter and governance systems, and the reappointment of the accounting firm. It also includes a legal opinion confirming the validity of the meeting and voting process. The document is not a full report but an official announcement of voting results from a shareholders meeting. The length is under 5,000 characters and it does not contain financial statements or detailed financial data. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-02-27 Chinese
广东信达律师事务所关于深圳市美好创亿医疗科技股份有限公司2024年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and proceedings of the company's 2024 first extraordinary general meeting (临时股东大会). It details the legality of the meeting's call, attendance, voting procedures, and results. It is not a financial report, earnings release, or management discussion, but a legal validation of the shareholder meeting process and voting outcomes. This type of document is typically classified under Declaration of Voting Results & Voting Rights Announcements (DVA) because it confirms the voting results and legality of the shareholder meeting. The document length is 3359 characters, which is consistent with a detailed legal opinion rather than a brief announcement or a full annual/interim report. Therefore, the appropriate classification is DVA with high confidence.
2024-02-27 Chinese
关于聘任公司财务总监的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new Chief Financial Officer (CFO) for the company Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It includes details about the appointment, qualifications, and compliance with regulatory requirements. There is no financial data, report, or presentation included. The document is clearly about a management change, specifically the hiring of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this announcement, confirming it is not a full report or other filing type.
2024-02-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.